Nigeria’s pharmaceutical system is entering a defining moment. For decades, it has operated with fragmented coordination, limited manufacturing capacity, and heavy dependence on donor-driven delivery models. Today, these long-standing pressures have reached a critical point. The departure of global pharmaceutical companies, rising medicine prices and the approaching 2028 transition away from vaccine funding have created an environment where the system to confront realities ca

Nigeria’s Joint Annual Review (JAR) 2025 offers one of the clearest signals yet that the country’s health sector is not just reforming it is transforming. Twenty-three months into the Health Sector Renewal Investment Initiative (NHSRII), the results are becoming visible, measurable, and scalable. This year’s review brought together leaders from Federal, State, and Local Governments, the private sector, civil society, and development partners under the theme: All Hands, One M